245 related articles for article (PubMed ID: 19420083)
21. HSV-1 DNA polymerase 3'-5' exonuclease-deficient mutant D368A exhibits severely reduced viral DNA synthesis and polymerase expression.
Lawler JL; Coen DM
J Gen Virol; 2018 Oct; 99(10):1432-1437. PubMed ID: 30176164
[TBL] [Abstract][Full Text] [Related]
22. Drug resistance patterns of recombinant herpes simplex virus DNA polymerase mutants generated with a set of overlapping cosmids and plasmids.
Bestman-Smith J; Boivin G
J Virol; 2003 Jul; 77(14):7820-9. PubMed ID: 12829822
[TBL] [Abstract][Full Text] [Related]
23. Impaired mismatch extension by a herpes simplex DNA polymerase mutant with an editing nuclease defect.
Baker RO; Hall JD
J Biol Chem; 1998 Sep; 273(37):24075-82. PubMed ID: 9727026
[TBL] [Abstract][Full Text] [Related]
24. An importin alpha/beta-recognized bipartite nuclear localization signal mediates targeting of the human herpes simplex virus type 1 DNA polymerase catalytic subunit pUL30 to the nucleus.
Alvisi G; Musiani D; Jans DA; Ripalti A
Biochemistry; 2007 Aug; 46(32):9155-63. PubMed ID: 17640102
[TBL] [Abstract][Full Text] [Related]
25. Mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene can confer altered drug sensitivities.
Hwang YT; Smith JF; Gao L; Hwang CB
Virology; 1998 Jul; 246(2):298-305. PubMed ID: 9657948
[TBL] [Abstract][Full Text] [Related]
26. The catalytic subunit of the DNA polymerase of herpes simplex virus type 1 interacts specifically with the C terminus of the UL8 component of the viral helicase-primase complex.
Marsden HS; McLean GW; Barnard EC; Francis GJ; MacEachran K; Murphy M; McVey G; Cross A; Abbotts AP; Stow ND
J Virol; 1997 Sep; 71(9):6390-7. PubMed ID: 9261356
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of translation by a short element in the 5' leader of the herpes simplex virus 1 DNA polymerase transcript.
Bryant KF; Coen DM
J Virol; 2008 Jan; 82(1):77-85. PubMed ID: 17959669
[TBL] [Abstract][Full Text] [Related]
28. Mutations within conserved motifs in the 3'-5' exonuclease domain of herpes simplex virus DNA polymerase.
Hall JD; Orth KL; Sander KL; Swihart BM; Senese RA
J Gen Virol; 1995 Dec; 76 ( Pt 12)():2999-3008. PubMed ID: 8847505
[TBL] [Abstract][Full Text] [Related]
29. DNA and protein interactions of the small subunit of herpes simplex virus type 1 DNA polymerase.
Franz C; Kühn FJ; Knopf CW
Virology; 1999 Jan; 253(1):55-64. PubMed ID: 9887318
[TBL] [Abstract][Full Text] [Related]
30. Analysis of in vitro activities of herpes simplex virus type 1 UL42 mutant proteins: correlation with in vivo function.
Thornton KE; Chaudhuri M; Monahan SJ; Grinstead LA; Parris DS
Virology; 2000 Sep; 275(2):373-90. PubMed ID: 10998337
[TBL] [Abstract][Full Text] [Related]
31. Polymerase and exonuclease activities in herpes simplex virus type 1 DNA polymerase are not highly coordinated.
Vashishtha AK; Kuchta RD
Biochemistry; 2015 Jan; 54(2):240-9. PubMed ID: 25517265
[TBL] [Abstract][Full Text] [Related]
32. The essential in vivo function of the herpes simplex virus UL42 protein correlates with its ability to stimulate the viral DNA polymerase in vitro.
Reddig PJ; Grinstead LA; Monahan SJ; Johnson PA; Parris DS
Virology; 1994 May; 200(2):447-56. PubMed ID: 8178434
[TBL] [Abstract][Full Text] [Related]
33. Processing of lagging-strand intermediates in vitro by herpes simplex virus type 1 DNA polymerase.
Zhu Y; Wu Z; Cardoso MC; Parris DS
J Virol; 2010 Aug; 84(15):7459-72. PubMed ID: 20444887
[TBL] [Abstract][Full Text] [Related]
34. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
[TBL] [Abstract][Full Text] [Related]
35. Evidence that the nuclease activities associated with the herpes simplex type 1 DNA polymerase are due to the 3'-5' exonuclease.
Hall JD; Orth KL; Claus-Walker D
J Virol; 1996 Jul; 70(7):4816-8. PubMed ID: 8676514
[TBL] [Abstract][Full Text] [Related]
36. Suicidal Phenotype of Proofreading-Deficient Herpes Simplex Virus 1 Polymerase Mutants.
Brunialti M; Höfler T; Nascimento M; Trimpert J
J Virol; 2023 Jan; 97(1):e0135922. PubMed ID: 36598203
[TBL] [Abstract][Full Text] [Related]
37. Effects of substitutions of arginine residues on the basic surface of herpes simplex virus UL42 support a role for DNA binding in processive DNA synthesis.
Randell JC; Komazin G; Jiang C; Hwang CB; Coen DM
J Virol; 2005 Sep; 79(18):12025-34. PubMed ID: 16140778
[TBL] [Abstract][Full Text] [Related]
38. Definition of herpes simplex virus type 1 helper activities for adeno-associated virus early replication events.
Alazard-Dany N; Nicolas A; Ploquin A; Strasser R; Greco A; Epstein AL; Fraefel C; Salvetti A
PLoS Pathog; 2009 Mar; 5(3):e1000340. PubMed ID: 19282980
[TBL] [Abstract][Full Text] [Related]
39. Assembly of complete, functionally active herpes simplex virus DNA replication compartments and recruitment of associated viral and cellular proteins in transient cotransfection assays.
Zhong L; Hayward GS
J Virol; 1997 Apr; 71(4):3146-60. PubMed ID: 9060678
[TBL] [Abstract][Full Text] [Related]
40. The herpes simplex virus type 1 DNA polymerase processivity factor increases fidelity without altering pre-steady-state rate constants for polymerization or excision.
Chaudhuri M; Song L; Parris DS
J Biol Chem; 2003 Mar; 278(11):8996-9004. PubMed ID: 12519753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
